These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51. Stevens MG; Olsen SC; Palmer MV; Pugh GW Infect Immun; 1996 Nov; 64(11):4534-41. PubMed ID: 8890203 [TBL] [Abstract][Full Text] [Related]
6. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis. Gupta S; Singh D; Gupta M; Bhatnagar R Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564 [TBL] [Abstract][Full Text] [Related]
7. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice. Truong QL; Cho Y; Park S; Park BK; Hahn TW Microb Pathog; 2016 Jun; 95():175-185. PubMed ID: 27057678 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Brucella abortus salt-extractable proteins. Tabatabai LB; Deyoe BL; Patterson JM Vet Microbiol; 1989 May; 20(1):49-58. PubMed ID: 2503922 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice. Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487 [TBL] [Abstract][Full Text] [Related]
10. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model. Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Brucella-extracted and recombinant protein vaccines in CD-1 and BALB/c mice. Pugh GW; Tabatabai LB; Bricker BJ; Mayfield JE; Phillips M; Zehr ES; Belzer CA Am J Vet Res; 1990 Sep; 51(9):1413-20. PubMed ID: 2118744 [TBL] [Abstract][Full Text] [Related]
12. Effect of Brucella abortus transfer factor in preventing murine brucellosis. Stevens MG; Pugh GW FEMS Immunol Med Microbiol; 1995 Jul; 11(4):279-84. PubMed ID: 8541805 [TBL] [Abstract][Full Text] [Related]
13. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice. Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952 [TBL] [Abstract][Full Text] [Related]
14. Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens. Bae JE; Schurig GG; Toth TE Vet Microbiol; 2002 Aug; 88(2):189-202. PubMed ID: 12135637 [TBL] [Abstract][Full Text] [Related]
15. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Stevens MG; Olsen SC; Pugh GW; Brees D Infect Immun; 1995 Jan; 63(1):264-70. PubMed ID: 7806364 [TBL] [Abstract][Full Text] [Related]
16. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308. Pugh GW; Phillips M; Tabatabai LB; McDonald TJ Vet Microbiol; 1991 Jan; 26(1-2):167-77. PubMed ID: 1902610 [TBL] [Abstract][Full Text] [Related]
17. Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308. Pugh GW; Zehr ES; Meador VP; Phillips M; McDonald TJ; Deyoe BL Am J Vet Res; 1989 Mar; 50(3):323-8. PubMed ID: 2494913 [TBL] [Abstract][Full Text] [Related]
18. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice. Phillips M; Pugh GW; Deyoe BL Am J Vet Res; 1989 Mar; 50(3):318-22. PubMed ID: 2494912 [TBL] [Abstract][Full Text] [Related]
19. Protective efficacy by various doses of a new brucellosis vaccine candidate based on Salmonella strains expressing Brucella abortus BSCP31, Omp3b and superoxide dismutase against brucellosis in murine model. Kim WK; Moon JY; Cho JS; Hur J Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28873944 [TBL] [Abstract][Full Text] [Related]
20. Substantial Protective Immunity Conferred by a Combination of Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]